UNPA: Does CFSAN’s plan for GMO labeling guidance signal a change of thinking at FDA?

NDIs, GRAS & GMOs: CFSAN outlines priorities for 2013-14

07-Oct-2013

By Stephen Daniells

The Food and Drug Administration's (FDA) Center for Food Safety and Applied Nutrition (CFSAN) has outlined its priorities for 2013-14, with a 'surprising' number relevant to supplements, including NDIs, GRAS, and GMOs.

UNPA seminar to help companies develop the strategies needed to serve personalized medicine market

24-Sep-2013

Jeffrey Bland, PhD, from the Personalized Lifestyle Medicine Institute, Jim Kean, CEO of WellnessFX, and Rich McKeown, from Leavitt Partners, are just three of the top names headlining the UNPA’s personalized medicine seminar to help companies best serve...

Going non-GMO in dietary supplements: ‘The supply community is not there with us yet’, say manufacturers

05-Jun-2013

By Stephen Daniells

Increasing consumer pressure and potential state legislation mandating labeling are leading dietary supplement manufacturers to face up to the challenges of going non-GMO, but the situation is complex and suppliers have more work to do than many would...

UNPA: Does CFSAN’s plan for GMO labeling guidance signal a change of thinking at FDA?

The Center for Food Safety and Applied Nutrition's (CFSAN) priority to publish guidance to help manufacturers with voluntarily GMO labeling could signal a change in thinking at the agency, says the United Natural Products Alliance (UNPA).

Related Topics

NDIs, GRAS & GMOs: CFSAN outlines priorities for 2013-14

UNPA seminar to help companies develop the strategies needed to serve personalized medicine market

Going non-GMO in dietary supplements: ‘The supply community is not there with us yet’, say manufacturers